Mitsubishi Tanabe Pharma America
Songjie Cai is a Clinical Research Scientist at Mitsubishi Tanabe Pharma America. Prior to this, Songjie worked as a Senior Scientist at Catamaran Bio, a Scientist at Takeda Oncology, and a Postdoctoral Research Scientist at Mass General Brigham. Songjie has a background in Medicine, holding a Doctor of Philosophy degree from Osaka University and an MD in Clinical Medicine from Shanghai Jiao Tong University. With experience in diagnosis, management, operative surgery, and post-operative care for Gastrointestinal, Pancreas, and Hepato-biliary diseases, Songjie has a strong foundation in the medical field.
This person is not in any offices
Mitsubishi Tanabe Pharma America
We are taking on the challenges of complex and debilitating conditions and are committed to meeting the needs of people suffering from serious and often life-threatening illnesses. Today, we are focused on driving scientific discovery in many areas. Our focus remains on bringing treatment to people living with ALS as we strive to make a meaningful difference in their lives. Many people living with amyotrophic lateral sclerosis (ALS) have unmet medical needs. We are committed to doing our best to find solutions that may help address those needs. We continue to expand our work to deepen our understanding of ALS, explore potential biomarkers to aid in further research and seek new answers. Every day we tackle tough challenges in science and medicine. Our teams work diligently to develop smart options that will enable healthcare providers to offer safe and effective treatments for devastating illnesses. Please see our LinkedIn community guidelines here: http://www.mt-pharma-america.com/pdf/LinkedIn-Community-Guidelines.pdf